<?xml version="1.0" encoding="UTF-8"?>
<p>Recent autopsy studies have permitted Brazilian COVID-19 patients to be treated as sufferers of Dissemination Intravascular of Coagulum (DIC), which can cause failure of several organs, mainly the lungs.
 <xref rid="B28" ref-type="bibr">
  <sup>28</sup>
 </xref> As a preliminary stage for combating the disease, Low Molecular Weight Heparin (LMWH) has been successfully administered.
 <xref rid="B29" ref-type="bibr">
  <sup>29</sup>
 </xref> In addition to its anticoagulant therapeutic effects, LMWH has demonstrated anti-inflammatory effects, endothelial protection and viral inhibition.
 <xref rid="B30" ref-type="bibr">
  <sup>30</sup>
 </xref> Rutin, displayed here as an active agent against 3CLpro and RdRp of SARS-CoV-2, has also proved to have anticoagulant therapeutic effects
 <xref rid="B31" ref-type="bibr">
  <sup>31</sup>
 </xref> as well as anti-inflammatory effects and potential protection against acute lung injury (ALI).
 <xref rid="B32" ref-type="bibr">
  <sup>32</sup>
 </xref> Intravenous or intranasal administration could be an alternative to oral intake, thus improving its bioavailability.
 <xref rid="B33" ref-type="bibr">
  <sup>33</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B34" ref-type="bibr">
  <sup>34</sup>
 </xref>
 <italic>D. ambrosioides</italic> has been used successfully by the riverside population in the Amazon Region for treating cases of acute respiratory distress syndrome (ARDS) and tuberculosis.
 <xref rid="B8" ref-type="bibr">
  <sup>8</sup>
 </xref> These results may also be related to the presence of rutin.
</p>
